Ophthalmology Management

11/20/2025

🔍 Smart ASCs focus on precision, integration, and collaboration.

At AAO 2025, leaders shared proven ways to streamline OR flow — from shaving seconds off turnover time to investing in tech that reduces friction rather than adds it.

Catch the key takeaways from the “ASC Optimization & Cost Containment” Symposium ⬇️
https://ow.ly/RCqx50XuxPa

The panel included Dan Chambers, Carrie Jacobs, Bansari Mehta, and Phil Meyer.

11/19/2025

👁️ The Complex Difference of CAM

Cryopreserved amniotic membrane is reshaping oculoplastics with anti-inflammatory, anti-scarring, and regenerative benefits. Practical pearls on graft selection, surgical technique, and when CAM outperforms mucous membrane or skin grafts.

📖 Read more in Ophthalmology Management: https://ow.ly/1Eni50XpVAj

11/18/2025

Is dry eye care entering a new phase?

A Lumenis panel at VisionExpo West outlined how clinicians are shifting toward targeted, technology-driven management. Experts highlighted overlooked factors such as lower lid laxity and the dominant role of MGD, emphasizing early screening and device-based treatments like IPL to address disease at its source.

They also noted rising dry eye rates in younger patients and stressed the need for dedicated dry eye services and cross-specialty collaboration.

Full story:
https://ow.ly/FMzw50XsWyf

11/17/2025

👁️ The November/December issue of Ophthalmology Management is here!

Have you read it yet? This issue looks ahead to the future of ophthalmic care — from innovation in presbyopia and pterygium treatments to evolving surgical techniques and smarter practice management.

📖 Explore the full digital edition: https://ow.ly/JzGm50XpVRe

11/14/2025

👀 New research offers the first real-time look at how VR headset use affects tear film dynamics.

Using a VR headset with a built-in micro-camera, researchers observed tear film changes and temperature increases during a 30-minute VR session — insights that may help guide future headset design and eye-comfort considerations.

👉 Read the full story via Ophthalmology Management: https://ow.ly/Y6Ee50XrbH7

11/13/2025

Optovue Solix by Visionix: Redefining OCT Excellence in Ophthalmic Practice

In this testimonial, Dr. Jay Bansal, MD, Medical Director at LaserVue Eye Center (CA), shares how the Optovue SOLIX has transformed his clinical workflow and patient care:
✅ Exceptional image quality — detailed, high-resolution, and high-density imaging
✅ Advanced diagnostic capabilities — offering a true edge in patient management
✅ Streamlined workflow — simplicity of scan acquisition enhances daily efficiency
✅ Outstanding support — Visionix provided comprehensive implementation assistance
“The Optovue Solix significantly enhances the efficiency and effectiveness of our practice.” — Dr. Jay Bansal, MD

🎥 Watch Dr. Bansal’s full interview here: https://www.youtube.com/watch?v=vp6hGlusxjw&t=2s

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

11/13/2025

👁️ Embrace Virtual Reality for Patient Education and Conversion

At the Eye Institute Of Utah, Zachary Zavodni, MD, is using virtual reality headsets to transform cataract consultations — helping patients understand IOL options before they even meet their provider.

The results?
✅ Shorter, more efficient educational sessions
✅ More confident, informed patients
✅ Higher premium IOL conversion rates

🎥 Discover how VR technology is reshaping ophthalmic education and patient engagement in OASC: https://ow.ly/qG5s50XnTcj

11/12/2025

👁️ Presbyopia Drops: A Foundation for Future Care

Presbyopia drops are reshaping how clinicians engage patients at the start of their vision-care journey. They’re not just a treatment, they’re an entry point for long-term patient relationships and proactive eye health management.

Key takeaways:
🔹 FDA-approved options: Qlosi, Vuity, Vizz
🔹 Flexible dosing tailored to lifestyle
🔹 Better patient satisfaction through education and expectation-setting

📖 Read more in Ophthalmology Management: https://ow.ly/e2H250XpSW0

11/11/2025

847 children. 36 months.

Sydnexis’ SYD-101 0.01% atropine slowed myopia progression and met all major endpoints in the phase 3 STAR trial.

Click here to read more 🔗 https://ow.ly/YRB350XnTqy

11/10/2025

👁️ Understanding when and how to remove pterygia is key to improving surgical outcomes and preventing recurrence.

In Ophthalmology Management, Richard Najac, MD, shares practical insights from daily experience treating pterygium — including timing of intervention, patient counseling, and the expanding role of cryopreserved amniotic membranes (CAMs) in reducing inflammation and recurrence.

Read how new tools, techniques, and therapies are making this once-painful surgery safer and more effective than ever.

🔗 https://ow.ly/FBNw50Xn0pM

11/07/2025

👁️ Your week in ophthalmology all in one place.

From clinical trial milestones and FDA updates to innovations in AI, retina, and cataract care, the Ophthalmology Management News section rounds up the stories that matter most this week.

Stay informed. Stay ahead. 📰
👉 https://ow.ly/Sh5B50X8m1N

11/06/2025

A recent case study shows early initiation of a complement-inhibitor treatment preserved independence and visual acuity in an 87-year-old patient. With flexible dosing and consistent monitoring, progression slowed and quality of life was maintained, highlighting the impact of timely intervention in GA management.
Learn more: https://bit.ly/47ZKld6